Annual Total Liabilities
$2.38 M
+$577.00 K+32.07%
31 December 2023
Summary:
Ampio Pharmaceuticals annual total liabilities is currently $2.38 million, with the most recent change of +$577.00 thousand (+32.07%) on 31 December 2023. During the last 3 years, it has fallen by -$2.99 million (-55.72%). AMPE annual total liabilities is now -95.20% below its all-time high of $49.49 million, reached on 31 December 2017.AMPE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$2.38 M
+$105.00 K+4.62%
31 December 2023
Summary:
Ampio Pharmaceuticals quarterly total liabilities is currently $2.38 million, with the most recent change of +$105.00 thousand (+4.62%) on 31 December 2023. Over the past year, it has increased by +$105.00 thousand (+4.62%). AMPE quarterly total liabilities is now -95.20% below its all-time high of $49.49 million, reached on 31 December 2017.AMPE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPE Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.1% | +4.6% |
| 3 y3 years | -55.7% | -54.3% |
| 5 y5 years | -73.0% | -79.9% |
AMPE Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -79.4% | +32.1% | -79.4% | +32.1% |
| 5 y | 5 years | -79.4% | +32.1% | -79.9% | +32.1% |
| alltime | all time | -95.2% | >+9999.0% | -95.2% | >+9999.0% |
Ampio Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $2.38 M(+32.1%) | $2.38 M(+4.6%) |
| Sept 2023 | - | $2.27 M(-12.3%) |
| June 2023 | - | $2.59 M(-9.4%) |
| Mar 2023 | - | $2.86 M(+58.8%) |
| Dec 2022 | $1.80 M(-84.4%) | $1.80 M(-63.9%) |
| Sept 2022 | - | $4.99 M(-29.9%) |
| June 2022 | - | $7.12 M(-32.4%) |
| Mar 2022 | - | $10.53 M(-8.7%) |
| Dec 2021 | $11.54 M(+115.1%) | $11.54 M(+122.0%) |
| Sept 2021 | - | $5.20 M(-18.1%) |
| June 2021 | - | $6.35 M(+28.3%) |
| Mar 2021 | - | $4.95 M(-7.8%) |
| Dec 2020 | $5.37 M(-29.0%) | $5.37 M(+11.4%) |
| Sept 2020 | - | $4.82 M(-12.7%) |
| June 2020 | - | $5.52 M(-19.5%) |
| Mar 2020 | - | $6.85 M(-9.3%) |
| Dec 2019 | $7.56 M(-14.1%) | $7.56 M(-36.1%) |
| Sept 2019 | - | $11.83 M(+20.9%) |
| June 2019 | - | $9.78 M(-25.1%) |
| Mar 2019 | - | $13.06 M(+48.5%) |
| Dec 2018 | $8.79 M(-82.2%) | $8.79 M(-34.1%) |
| Sept 2018 | - | $13.34 M(-13.6%) |
| June 2018 | - | $15.44 M(-34.4%) |
| Mar 2018 | - | $23.52 M(-52.5%) |
| Dec 2017 | $49.49 M(+610.9%) | $49.49 M(+416.3%) |
| Sept 2017 | - | $9.59 M(+2.7%) |
| June 2017 | - | $9.33 M(+60.4%) |
| Mar 2017 | - | $5.82 M(-16.4%) |
| Dec 2016 | $6.96 M(-44.3%) | $6.96 M(-1.3%) |
| Sept 2016 | - | $7.05 M(+118.8%) |
| June 2016 | - | $3.22 M(-18.1%) |
| Mar 2016 | - | $3.93 M(-68.5%) |
| Dec 2015 | $12.49 M | $12.49 M(+17.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $10.61 M(+130.3%) |
| June 2015 | - | $4.61 M(+39.4%) |
| Mar 2015 | - | $3.31 M(-31.3%) |
| Dec 2014 | $4.81 M(+71.5%) | $4.81 M(+12.6%) |
| Sept 2014 | - | $4.27 M(-15.8%) |
| June 2014 | - | $5.07 M(-5.9%) |
| Mar 2014 | - | $5.39 M(+92.3%) |
| Dec 2013 | $2.80 M(+39.0%) | $2.80 M(+15.4%) |
| Sept 2013 | - | $2.43 M(-12.9%) |
| June 2013 | - | $2.79 M(+33.3%) |
| Mar 2013 | - | $2.09 M(+3.7%) |
| Dec 2012 | $2.02 M(+17.1%) | $2.02 M(+19.3%) |
| Sept 2012 | - | $1.69 M(+12.6%) |
| June 2012 | - | $1.50 M(+13.0%) |
| Mar 2012 | - | $1.33 M(-22.9%) |
| Dec 2011 | $1.72 M(-63.7%) | $1.72 M(-19.3%) |
| Sept 2011 | - | $2.14 M(-10.2%) |
| June 2011 | - | $2.38 M(+18.2%) |
| Mar 2011 | - | $2.01 M(-57.6%) |
| Dec 2010 | $4.75 M(+1239.5%) | $4.75 M(+192.2%) |
| Sept 2010 | - | $1.62 M(+69.0%) |
| June 2010 | - | $961.20 K(+76.9%) |
| Mar 2010 | - | $543.40 K(+53.4%) |
| Dec 2009 | $354.30 K(+361.3%) | $354.30 K(+274.9%) |
| Sept 2009 | - | $94.50 K(+4.5%) |
| June 2009 | - | $90.40 K(+3.9%) |
| Mar 2009 | - | $87.00 K(+13.3%) |
| Dec 2008 | $76.80 K(+75.7%) | $76.80 K(+10.2%) |
| Sept 2008 | - | $69.70 K(+4.8%) |
| June 2008 | - | $66.50 K(+11.6%) |
| Mar 2008 | - | $59.60 K(+36.4%) |
| Dec 2007 | $43.70 K(+332.7%) | $43.70 K(+2.3%) |
| Sept 2007 | - | $42.70 K(+322.8%) |
| Dec 2006 | $10.10 K | $10.10 K |
FAQ
- What is Ampio Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual total liabilities year-on-year change?
- What is Ampio Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly total liabilities year-on-year change?
What is Ampio Pharmaceuticals annual total liabilities?
The current annual total liabilities of AMPE is $2.38 M
What is the all time high annual total liabilities for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual total liabilities is $49.49 M
What is Ampio Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, AMPE annual total liabilities has changed by +$577.00 K (+32.07%)
What is Ampio Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of AMPE is $2.38 M
What is the all time high quarterly total liabilities for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly total liabilities is $49.49 M
What is Ampio Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, AMPE quarterly total liabilities has changed by +$105.00 K (+4.62%)